On 2 December, Alzheimer Europe (AE) hosted a Company Round Table meeting in Brussels. The meeting was a hybrid event, with many participants attending in person and some joining remotely. The meeting brought together company representatives from Anavex, BioArctic, Biogen, Danone (Nutricia), Eisai, Eli Lilly, GE HealthCare, Johnson & Johnson, MSD, Novo Nordisk, Roche and UCB, alongside AE staff and members from national Alzheimer organisations. The event was moderated by AE chairperson Rosário Zincke dos Reis and featured four presentations. First, Cindy Birck, AE Project Officer, gave an update on our Clinical Trials Watch, an online database providing accessible and up-to-date information on clinical trials that are investigating drugs for Alzheimer’s disease and/or dementia.
Next, Owen Miller, AE Project Officer, shared some updates on EU policy developments. Then, Jean Georges, AE Executive Director gave an overview of the annual conference held in October in Bologna. Finally, Lukas Duffner, AE Project Officer, presented the public opinion poll, launched this year by AE, aiming to examine attitudes towards dementia research participation and data sharing. We would like to thank our sponsors and members for participating in this meeting and we look forward to welcoming them to the next Company Round Table meeting, which will take place in Brussels on 17 March 2026.
